000			02415 a2200781 4500
005			20250517191931.0
264		0	_c20190219
008			201902s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2017.338 _2doi
040			_aNLM _beng _cNLM
100	1		_aPeter, B
245	0	0	_aDrug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. _h[electronic resource]
260			_bLeukemia _c04 2018
300			_a1016-1022 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Cycle Checkpoints _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDasatinib _xpharmacology
650	0	4	_aDogs
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aG2 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukemia, Mast-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMast Cells _xdrug effects
650	0	4	_aMastocytosis, Systemic _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aNorbornanes _xpharmacology
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-kit _xmetabolism
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aSTAT5 Transcription Factor _xmetabolism
650	0	4	_aStaurosporine _xanalogs & derivatives
650	0	4	_aTumor Suppressor Proteins _xmetabolism
650	0	4	_aYoung Adult
700	1		_aBibi, S
700	1		_aEisenwort, G
700	1		_aWingelhofer, B
700	1		_aBerger, D
700	1		_aStefanzl, G
700	1		_aBlatt, K
700	1		_aHerrmann, H
700	1		_aHadzijusufovic, E
700	1		_aHoermann, G
700	1		_aHoffmann, T
700	1		_aSchwaab, J
700	1		_aJawhar, M
700	1		_aWillmann, M
700	1		_aSperr, W R
700	1		_aZuber, J
700	1		_aSotlar, K
700	1		_aHorny, H-P
700	1		_aMoriggl, R
700	1		_aReiter, A
700	1		_aArock, M
700	1		_aValent, P
773	0		_tLeukemia _gvol. 32 _gno. 4 _gp. 1016-1022
856	4	0	_uhttps://doi.org/10.1038/leu.2017.338 _zAvailable from publisher's website
999			_c27898051 _d27898051